Pages that link to "Q28076453"
Jump to navigation
Jump to search
The following pages link to Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC) (Q28076453):
Displayed 14 items.
- Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia (Q41348351) (← links)
- Cholangitis: Diagnosis, Treatment and Prognosis (Q47137991) (← links)
- Therapeutic potential of phages in autoimmune liver diseases (Q47269751) (← links)
- Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium. (Q53136572) (← links)
- Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems (Q57106957) (← links)
- Diagnostic and therapeutic potentials of microRNAs in cholangiopathies (Q57128794) (← links)
- Gut⁻Liver Axis: How Do Gut Bacteria Influence the Liver? (Q58729616) (← links)
- The gut-liver axis and the intersection with the microbiome (Q88634168) (← links)
- Publisher Correction: The gut-liver axis and the intersection with the microbiome (Q88764776) (← links)
- The role of the gut microbiome in chronic liver disease: the clinical evidence revised (Q89624002) (← links)
- Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology (Q90461761) (← links)
- Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either (Q91611230) (← links)
- Autoimmune liver disease and the enteric microbiome (Q91788029) (← links)
- Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota (Q91919553) (← links)